Treatment adherence and long-term outcomes

被引:71
|
作者
Kane, John M. [1 ]
机构
[1] N Shore Long Isl Jewish Hlth Syst, Behav Hlth Serv, Great Neck, NY 11021 USA
[2] Zucker Hillside Hosp, Dept Psychiat, Glen Oaks, NY USA
[3] Albert Einstein Coll Med, New York, NY USA
关键词
RANDOMIZED CONTROLLED-TRIAL; COMPLIANCE THERAPY; SCHIZOAFFECTIVE DISORDER; MEDICATION ADHERENCE; 1ST-EPISODE SCHIZOPHRENIA; 1ST EPISODE; RELAPSE; RISK; NONADHERENCE; PREDICTORS;
D O I
10.1017/S1092852900026304
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The successful management of schizophrenia is an enormous public health issue. Although antipsychotic medications can be very helpful in reducing rates of relapse and rehospitalization, nonadherence to medication is a frequent cause of exacerbations in psychopathology, psychotic relapse, and rehospitalization. Relapses can have devastating consequences in a variety of clinical and functional domains. Nonadherence can result from a variety of factors that vary from patient to patient and vary over time in individual patients. A number of strategies have been developed to assess and facilitate adherence. The first critical step is clinician awareness of the scope of the problem and consideration of appropriate strategies to address it.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 50 条
  • [21] Adherence in long-term treatment with antipsychotics: Problems and future perspectives
    Canas, Fernando
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 : 23 - 23
  • [22] Initial motivation predicts long-term adherence to pharmacological treatment
    Garcia-Cabeza, I.
    Olmeda, M. S.
    Salgado, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S567 - S568
  • [23] The role of adherence to medication in the effectiveness of long-term treatment of schizophrenia
    Volavka, J.
    Lindenmayer, J. P.
    Liu-Seifert, H.
    Kulkarni, P.
    Kinon, B. J.
    Stauffer, V.
    Edwards, B.
    Chen, L.
    Adams, D. H.
    Buckley, P. F.
    Citrome, L.
    EUROPEAN PSYCHIATRY, 2007, 22 : S54 - S55
  • [24] Ethnic Similarity, Therapist Adherence, and Long-Term Multisystemic Therapy Outcomes
    Chapman, Jason E.
    Schoenwald, Sonja K.
    JOURNAL OF EMOTIONAL AND BEHAVIORAL DISORDERS, 2011, 19 (01) : 3 - 16
  • [25] Adherence to treatment: The key for avoiding long-term complications of diabetes
    Lerman, I
    ARCHIVES OF MEDICAL RESEARCH, 2005, 36 (03) : 300 - 306
  • [26] ASSESSING THE IMPACT OF MEDICATION ADHERENCE ON LONG-TERM OUTCOMES IN PATIENTS WITH DIABETES
    Bansilal, Sameer
    Wei, Henry G.
    Castellano, Jose
    Garrido, Ester
    Freeman, Allison N.
    Sanz, Gines
    Garcia-Alonso, Fernando
    Spettell, Claire M.
    Steinberg, Gregory
    Fuster, Valentin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1409 - A1409
  • [27] Patient adherence to long-term medical treatment of kidney stones
    Parks, JH
    Asplin, JR
    Coe, FL
    JOURNAL OF UROLOGY, 2001, 166 (06): : 2057 - 2060
  • [28] Long-term outcomes
    Mathus-Vliegen, Lisbeth
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S11 - S11
  • [29] Long-Term Outcomes of Myeloid Growth Factor Treatment
    Lyman, Gary H.
    Dale, David C.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (08): : 945 - 952
  • [30] Long-term treatment goals: Enhancing healthy outcomes
    Casey, DE
    CNS SPECTRUMS, 2003, 8 (11) : 26 - 28